English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 14 August 2012, 05:25 HKT/SGT
Share:
    

Source: INC Research, LLC
INC Research Launches "Perspectives" Webinar Series Providing Insights from Key Industry Thought Leaders on the Latest Thinking in Clinical Research
Upcoming Series includes Eight Sessions Focusing on Therapeutic Insights, Emerging Issues in Clinical Development and the Latest on FSP Partnerships

Raleigh, NC, Aug 14, 2012 - (ACN Newswire) - INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, today announced the launch of its "Perspectives" webinar series designed to bring together key industry experts and thought leaders to share the latest insights and best practices on the many facets of clinical research. INC Research thought leaders will participate in discussions along with a well-rounded group of industry experts, to provide valuable and practical knowledge on such topics as therapeutic insights on clinical trial design, emerging issues in clinical development and the latest on Functional Service Provider (FSP) partnerships.

"The 'Perspectives' series is designed to spotlight the latest developments and best practices in clinical research today," said Alistair Macdonald, President, Clinical Development Services, INC Research. "By sharing experiences on the emerging and most impactful areas of clinical research, we will provide practical information that attendees can incorporate in their day-to-day activities, as well as key insights related to broader strategic issues. With exclusive access to industry leaders, attendees will have a unique opportunity to get answers to their most thought-provoking questions on issues that matter most."

INC's "Perspectives" series kicks off Aug. 28 and includes eight one-hour sessions, concluding mid-November with "Regulatory and Ethics Committees in the United States: Perspectives on Pediatrics Clinical Trials." Further reinforcing the Company's therapeutic focus, the webinar series features three therapeutic sessions on wide-ranging topics, including "Early Phase Oncology Transitional Studies," "Microbiology Operations in Infectious Disease Clinical Trials," and "Recent Important Diabetes Studies - Implications for Clinical Practice."

To learn more about "Perspectives" or to register for the upcoming series, visit www.incresearch.com/perspectives .

About INC Research, LLC

INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areasand innovative pediatric and women's health trials. The Company's Trusted Process(R) methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.

Contact: Lori Dorer, Media +1-513-345-1685


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: INC RESEARCH, LLC via Thomson Reuters ONE

Topic: Press release summary
Source: INC Research, LLC


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

INC Research, LLC Related News
Nov 7, 2014 08:50 HKT/SGT
INC Research Announces Pricing of Initial Public Offering
Oct 7, 2014 07:10 HKT/SGT
INC Research Files Registration Statement for Initial Public Offering
Oct 3, 2014 10:30 HKT/SGT
INC Research Demonstrates Continued Dedication to Site Relationships at 2014 SCRS Site Solutions Summit
Oct 2, 2014 07:20 HKT/SGT
INC Research Further Reinforces Commitment to Clinical Research Sites and Patients through Creation of New Leadership Role
Aug 6, 2014 03:30 HKT/SGT
INC Research's Tara Fitzgerald and Judy Swilley Named to Annual PharmaVOICE 100
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575